<DOC>
	<DOCNO>NCT01578330</DOCNO>
	<brief_summary>The study ass patient ' satisfaction treatment 12 month treatment fingolimod It also assess tolerability profile fingolimod small population .</brief_summary>
	<brief_title>A 12 -Month , Open-label , Multi-center Study Explore Health Outcomes FTY720</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>1 . Diagnosed RRMS described 2005 Mc Donald criteria 2 . Provided write informed consent prior intervention 3 . Female male patient age 1865 year 4 . Unresponsive treatment beta interferon glatiramer acetate minimum one year adequate dose high disease activity ( Unresponsive patient : patient change relapse , increased relapse , severer relapse oneyear treatment least one relapse past one year previous treatment one multiple contrast enhance lesion cranial MRI increase T2 lesion successive MRIs ) 5 . EDSS score 5.5 baseline Treatmentnaive RRMS patient 2 . History chronic disease immune system MS know immunodeficiency 3 . Past current malignancy 4 . Diabetic patient mild severe , nonproliferative proliferative diabetic retinopathy uncontrolled diabetic patient HbA1c &gt; 8 % 5 . Evidence macular edema ( patient history macular edema allow enter study provide macular edema screening . ) 6 . Evidence uveitis 7 . EDSS score &gt; 5.5 baseline 8 . Active systemic bacterial , viral fungal infection , know AIDS , Hepatitis B , Hepatitis C infection positive HIV antibody , Hepatitis B surface antigen Hepatitis C antibody test 9 . No history varicella negative varicellazoster virus IhH antibody test screening ( patient may include administered VZV vaccine , least 1 month follow vaccination . ) 10 . Patients receive live live attenuate vaccine last one month ( include varicellazoster virus measles ) 11 . Patients receive total lymphoid irradiation bone marrow transplantation 12 . Patient receive treatment : 1 . Corticosteroids adrenocorticotropic hormone ( ACTH ) last 1 month 2 . Immunosuppressive medication azathioprine methotrexate etc . 3 . Immunoglobulin treatment last 3 month 4 . Cladribine , cyclophosphamide , mitoxantrone , natalizumab time 13 . Patients follow cardiovascular condition : Resting heart rate &lt; 45 bpm/min Cardiac failure time screening ( Class III accord NYHA classification ) severe cardiac determine physician Myocardial infarction last 6 month History Mobitz Type II grade 2 AV block Past current grade 3 AV block Confirmed history sick sinus syndrome sinoatrial heart block arrhythmia require current treatment Class Ia drug ( ajmaline , disopyramid , procainamide , quinidine ) hypertension uncontrolled medication 14 . Patients pulmonary condition severe respiratory disease pulmonary fibrosis Uncontrolled asthma 15 . Pregnant nursing ( lactate ) woman ( pregnancy define state female conception termination gestation confirm positive hCG laboratory test ( &gt; 5 mIU/ml ) . 16 . Patients hepatic condition : Alcohol abuse , chronic hepatic biliary disease , severe hepatic impairment ( Child Pugh class C ) Total bilirubin upper limit normal provide associated Gilbert 's syndrome Conjugated bilirubin upper limit normal Alkaline phosphate ( AP ) 1.5 time upper limit normal AST ( SGOT ) , ALT ( SGPT ) 2 time upper limit normal , gammaglutamyltransferase ( GGT ) 3 time upper limit normal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Relapsing remit multiple sclerosis</keyword>
	<keyword>Fingolimod</keyword>
	<keyword>FTY720</keyword>
</DOC>